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Background: Surgical site infections (SSIs) are difficult to treat and are associated with substantially longer hospital
stay, higher treatment cost, morbidity and mortality, particularly when the etiological agent is multidrug-resistant
(MDR). To address the limited data in Uganda on SSIs, we present the spectrum of bacteria isolated from
hospitalized patients, the magnitude and impact of MDR bacterial isolates among patients with SSIs.
Methods: A descriptive cross sectional study was conducted from September 2011 through April 2012 involving
314 patients with SSIs in the obstetrics & gynecology, general surgery and orthopedic wards at Mulago National
Hospital in Kampala, Uganda. Wound swabs were taken and processed using standard microbiological methods.
Clinico-demographic characteristics of patients were obtained using structured questionnaires and patients’ files.
Results: Of the 314 enrolled patients with SSIs (mean age 29.7 ±13.14 years), 239 (76.1%) were female. More than
half of the patients were from obstetrics and gynecology (62.1%, 195/314). Of 314 wound swabs taken, 68.8%
(216/314) were culture positive aerobically, yielding 304 bacterial isolates; of which 23.7% (72/304) were Escherichia
coli and 21.1% (64/304) were Staphylococcus aureus. More than three quarters of Enterobacteriaceae were found to
be extended spectrum beta lactamase (ESBL) producers and 37.5% of S. aureus were Methicillin resistant S. aureus
(MRSA). MDR occurred in 78.3% (238/304) of the isolates; these were more among Gram-negative bacteria (78.6%,
187/238) compared to Gram-positive bacteria (21.4%, 51/238), (p-value < 0.0001, χ2 = 49.219). Amikacin and
imepenem for ESBL-producing Enterobacteriacea and vancomycin for MRSA showed excellent performance except
that they remain expensive drugs in Uganda.
Conclusion: Most SSIs at Mulago National Hospital are due to MDR bacteria. Isolation of MRSA and ESBL-producing
Enterobacteriaceae in higher proportions than previously reported calls for laboratory guided SSIs- therapy and
strengthening of infection control surveillance in this setting.
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Surgical site infections (SSIs) are the infections involving
skin, subcutaneous tissue and organs/spaces opened or
manipulated during an operation, occurring within 30 days
after the procedure or within one year if orthopedic im-
plant is in situ [1,2]. SSIs account for approximately 15.0%* Correspondence: senijj80@gmail.com
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reproduction in any medium, provided the orand rank third among all types of nosocomial infections in
the USA [2,3]. Infection rates among operated patients var-
ies with hospital settings reflecting infection control prac-
tices as well as factors related to the agent, environment
and the host [4]; for example, infection rates reported were
less than 3.0% in German and France, 16.9% in Rio de
Janeiro, Brazil and 26.0% in Mwanza, Tanzania [5-8]. SSIs
can involve any surgical procedure ranging from obstetrics
& gynecology, general surgery and orthopedic [6,9,10].
The most predominant bacteria in hospital-acquired SSIs
are Staphylococcus aureus, Enterococcus spp, Pseudomonas. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of these, single bacterial isolates are common whereas 9.0%
to 27.0% of bacterial isolates from different surgical sites are
attributed to polymicrobial [7-9,11]. These infections pose
therapeutic challenges and are associated with substantially
longer duration of hospital stay, increased hospital cost,
higher morbidity and mortality [5,12], particularly when the
agents are Methicillin resistant S. aureus (MRSA), Extended
spectrum beta lactamase (ESBL) producing Enterobacte-
riaceae and/or other agents collectively referred to as
multidrug-resistant (MDR) [11,13,14]. Studies from devel-
oping countries have shown high level of resistance (ran-
ging from 50 to 100%) to the commonly used antibiotics
like ampicillin, trimethoprim – sulphamethoxazole, genta-
micin, chloramphenicol and third generation cephalospo-
rins among S. aureus, E. coli, and P. aeruginosa [8,15] as
opposed to low rates of resistance ranging from 0-50%
in developed countries [16]. In both settings however, sub-
stantial rates of resistance to oxacillin, erythromycin and
clindamycin reported for S. aureus, ranged from 10-60%
[8,9,15,16] whereas vancomycin (for S. aureus and other
Gram-positive bacteria), amikacin, piperacillin-tazobactam
and imepenem (for E. coli, P. aeruginosa and other Gram-
negative bacteria) showed resistant rates of less than 25%
[17,18].
It is well known that specific therapeutic options to
patients with SSIs are largely dependent on data from
antimicrobial sensitivity tests generated by clinical la-
boratories or sound epidemiological data from ongoing
nosocomial infection surveillance [6,11,19].
In Uganda, about 10% of the surgical procedures be-
come septic accounting for an increasing morbidity and
mortality, with the commonest organism isolated being
S. aureus [20-22]; however data on the spectrum of bac-
teria isolated from hospitalized patients and their anti-
microbial susceptibility patterns to guide SSI-therapy in
Mulago National Hospital remains scanty. Furthermore,
the magnitude and impact of MDR bacteria from SSIs
are unknown. Thus, this study aimed at addressing these
areas. Data herein will be crucial in guiding SSIs-therapy
and will form a baseline for nosocomial SSIs surveillance.
Methods
Study design and sampling process
This descriptive cross-sectional study was conducted at
Mulago National Hospital in Kampala, Uganda. The hos-
pital is located on Mulago Hill in the northern part of the
city of Kampala and is the largest hospital in Uganda with
an estimated 1,500 beds.
The study was conducted for a period of 8 months
from September 2011 to April 2012 and involved 314
patients with clinical SSIs who consented to participate.
The patients were from obstetrics & gynecology, general
surgery and orthopedic wards. All patients with SSIsoccurring within 30 days after the operative procedure
or within one year if orthopedic implant was in situ were
included, whereas surgical patients with community-
acquired pyogenic infections such as abscess, furuncle and
carbuncles; patients with infection of an episiotomy; and
patients with open fractures were excluded from the study.
Study clearance and ethical considerations
The study got ethical clearance from the Institutional
Review Board (IRB) of Makerere University College of
Health Sciences (# REC REF 2011–183), Mulago Hos-
pital Research Committee (MREC #125) and the Uganda
National Council for Science and Technology (UNCST)
(REF # HS 1080). A written informed consent from each
patient/caretaker and assent for minors (11 to 17years)
were obtained whereas for each minor (<11 years), con-
sent was obtained from his/her parent or caretaker. All
patient information was kept confidential and anonym-
ous using codes.
Data collection and laboratory procedures
Demographic and clinical characteristics from patients were
collected using structured questionnaire and from patients’
files (see Additional file 1). The infected site was cleaned
using normal saline and sterile gauze then, from each pa-
tient, two wound swabs were collected using sterile cotton
swabs in Amies transport media (Biolab, HUNGARY®).
Isolate identification
Wound swabs were processed in the bacteriology labora-
tory of the Department of Medical Microbiology, Makerere
University College of Health Sciences, within 2 hours of
collection. The first wound swab was used to make Gram
stain smears while the second one was inoculated into
blood agar, MacConkey agar, and mannitol-salt agar and
incubated at 35-37°C for 24–48 hours. Identification of
bacteria was based on conventional physiological and bio-
chemical methods such as Gram stain, catalase reaction,
coagulase test, DNase test, hemolytic activity on sheep
blood agar plates, bacitracin, optochin and trimethoprim-
sulphamethoxazole (SXT) antimicrobial identification disks
and bile esculin test for Gram-positive bacteria. Gram-
negative bacteria were identified based on colony morph-
ology on blood agar and MacConkey agar, followed by
biochemical reactions namely oxidase, triple sugar iron
(TSI), sulphur indole and motility (SIM), citrate, and ure-
ase tests [23].
Drug susceptibility tests
Following identification of the bacterial isolates, a
standard disc diffusion technique for drug susceptibility
test (DST) was performed as recommended by Clinical
and Laboratory Standard Institute (CLSI) [24]. For Gram-
positive bacteria, discs (Biolab®, HUNGARY) tested were
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phamethoxazole (1.25/23.75 μg), tetracycline (30 μg),
ciprofloxacin (5 μg), chloramphenicol (30 μg), gentami-
cin (10 μg) [high level gentamicin (120 μg) for Entero-
coccus spp], erythromycin (15 μg), clindamycin (2 μg),
and vancomycin (30 μg). For Gram-negative bacteria
discs (Biolab®, HUNGARY) tested included ampicillin
(10 μg), piperacillin(100 μg), piperacillin-tazobactam
(100/10 μg), amoxicillin-clavulanic acid (20/10 μg),
trimethoprim-sulphamethoxazole (1.25/23.75 μg), tetra-
cycline (30 μg), ciprofloxacin (5 μg), chloramphenicol
(30 μg), gentamicin (10 μg), amikacin (30 μg), ceftriax-
one (30 μg), ceftazidime (30 μg), cefepime (30 μg), and
imipenem (10 μg). These were incubated at 35-37°C for
24 hours.
Isolates which were not identifiable by the standard
conventional methods, colistin DST for all Acinetobacter
spp and P. aeruginosa as well as vancomycin DST for all
S. aureus were confirmed using the Phoenix Automated
instrument® (Becton-Dickson, Sparks Maryland) as per
manufacturer’s instruction.
For determining inducible clindamycin resistance, clin-
damycin disk (2 μg) and erythromycin disk (15 μg) were
placed side by side approximately 15-26 mm apart. Flat-
tening of the zone of inhibition adjacent to the eryth-
romycin disk was regarded as a positive D-test. As
recommended by CLSI, isolates were screened for ESBL
production using the double disc method and MRSA was
identified by the use of cefoxitin disc (30 μg) [24,25].
MDR was defined as an isolate with resistance to three or
more antimicrobial classes [26].
Results on isolate identity and antimicrobial suscepti-
bility patterns were promptly reported to the attending
doctor for patient care.
Quality control
Reference strains S. aureus ATCC 25923 and Staphylo-
coccus epidermidis ATCC 12228 for Gram-positive bac-
teria and E. coli ATCC 25922 and P. aeruginosa ATCC
27853 for Gram-negative bacteria were used to quality-
control microbiological procedures such as Gram staining ,
growth of bacteria on respective media, microscopy, bio-
chemical identification tests and drug susceptibility testing.
Data analysis
Variables from the clinical and demographic data in the
questionnaire and laboratory data were entered into
Excel®, cleaned and exported to STATA software version
11 (College Station, Texas, USA) for analysis according
to the objectives of the study. Continuous variables were
described as mean (± standard deviation). Categorical
variables were described as proportion and were ana-
lyzed to compare the significance of difference in distri-
bution by using Chi square test or Fischer’s exact testwhere appropriate. To determine factors associated with
bacteria isolation from SSI, we used univariate followed
by multivariate logistic regression analysis. At univariate
level all factors which had a p-value of less than 0.05
were subjected to multivariate analysis. The strength of
association between factors and outcome was measured
using odds ratio with respective 95% confidence interval.
Factors with p-value of less than 0.05 on multivariate lo-
gistic regression analysis were considered as independent
association of bacteria isolation from SSI.Results
This study enrolled 314 patients with clinical SSIs. Among
these, 239 (76.1%) were female. The overall mean age was
29.7 ± 13.14 years (minimum 12 and maximum 83 years).
More than half of the patients were from obstetrics and
gynecology wards, 62.1% (195/314), whereas 33.1% (104/
314) and 4.8% (15/314) were from general surgery and
orthopedic wards respectively. The most common surgical
procedures were caesarean section 46.2% (145/314) and
laparotomy 42.7% (134/314); open reduction and internal
fixation (ORIF) accounted for 3.5% (11/314) while other
surgical procedures contributed 7.6% (24/314).
Of the 314 non-repeat wound swabs collected, 216
(68.8%) were culture positive aerobically. The most pre-
dominant bacterial isolates were E. coli, 23.7% (72/304)
and S. aureus, 21.1% (64/304) (see Figure 1). Single bac-
terial isolates were recovered from 137 (63.4%) patients
whereas 79 (36.6%) had polymicrobial infections.
All P. aeruginosa isolates were sensitive to colistin,
whereas 3.9% (2/52) of Acinetobacter spp were resistant
to colistin. All Gram-negative bacteria were susceptible
to imipemen, except 3.9% (2/52) of Acinetobacter spp.
All S. aureus isolates were sensitive to vancomycin,
whereas one Enterococcus spp [4.4% (1/23)] was resistant
to vancomycin i.e. VRE (see Table 1).
More than three quarters of Enterobacteriaceae were
phenotypically found to be ESBL producers [E. coli, 79.2%
(57/72); Klebsiella spp, 92.3% (36/39) and other Entero-
bacteriaceae, 73.5% (25/34)]. The proportion of MRSA
among S. aureus isolates was 37.5% (24/64).
Of the 304 isolates recovered from SSIs, 78.3% (238/304)
were MDR, these were found significantly more among
Gram-negative bacteria (78.6%, 187/238) compared to
Gram-positive bacteria (21.4%, 51/238) (p-value < 0.0001,
χ2 = 49.219).
In the univariate analysis, bacterial isolation from SSIs
among patients was associated with age greater than 40
years, sex, ward type, operation (whether elective or emer-
gency), duration from admission to operation, duration
from admission to discharge, type of antibiotic chemo-
prophylaxis given, duration of postoperative antibiotics
and outcome (see Table 2).
Figure 1 Proportion of bacterial isolates from patients with surgical site infections (N = 304). Other g- bacteria: Enterobacter cloacae (10),
Proteus mirabilis (7), Morganella morganii (6), Providencia spp (5), Citrobacter freundii (4), Serratia marcescens (1) and Leclercia adecarboxylata (1);
Other g + bacteria: Streptococcus pyogenes (3), Streptococcus agalactiae (1), and Streptococcus spp (4).Acinetobacter spp: Acinetobacter baumanii (48)
and Acinetobacter baumanii-calcoaceticus complex (4); Klebsiella spp: Klebsiella pneumonia (35) and Klebsiella oxytoca (4); Enterococcus spp:
Enterococcus faecalis (21) and Enterococcus faecium (2).
Table 1 Antimicrobial resistance pattern among isolates from surgical site infections














spp (n = 23)
Other g +
(n = 08)
Ampicillin 100.0% 100.0% NA NA 97.1% 100.0% 30.0% 50.0%
Piperacillin NA NA 100.0% 66.7% NA NA NA NA
TZP* 30.6% 38.5% 53.8% 16.7% 32.4% NA NA NA
AMC+ 90.3% 100.0% NA NA 94.1% NA NA NA
TMP-SMX × 86.1% 92.3% 98.0% 100.0% 94.1% 89.1% NA 80.0%
Tetracycline 72.2% 76.9% 65.4% 100.0% 82.4% 42.2% 74.0% 62.5%
Ciprofloxacin 72.2% 66.6% 77.0% 16.7% 47.1% 29.7% 60.9% 50.0%
Chloramphenicol 41.7% 71.8% NA NA 70.6% 15.6% 30.4% 37.5%
Gentamicin 54.2% 76.9% 88.5% 16.7% 76.5% 18.8% 21.7%** 50.0%
Amikacin 4.2% 2.6% 32.7% 8.3% 0.0% NA NA NA
Ceftriaxone 77.8% 92.3% NA NA 67.6% NA NA NA
Ceftazidime 77.8% 87.2% 90.4% 25.0% 61.8% NA NA NA
Cefepime 69.4% 87.2% 61.5% 16.7% 38.2% NA NA NA
Imipenem 0.0% 0.0% 3.9% 0.0% 0.0% NA NA NA
Erythromycin NA NA NA NA NA 46.9 % 65.2% 50.0%
Clindamycin NA NA NA NA NA 40.6% NA 62.5%
Vancomycin NA NA NA NA NA 0.0% 4.4% 0.0%
*Piperacillin-tazobactam, +Amoxicillin-clavulanate, ×Trimethoprim-sulphamethoxazole, ** High level resistance screening, NA: Not applicable, spp: species, g+:
Gram-positive bacteria [Streptococcus pyogenes (3), Streptococcus agalactiae (1), and Streptococcus spp (4)] and g-: Gram-negative bacteria [Enterobacter cloacae
(10), Proteus mirabilis (7), Morganella morganii (6), Providencia spp (5), Citrobacter freundii (4), Serratia marcescens (1) and Leclercia adecarboxylata (1)].
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Table 2 Association of clinico-demographic characteristics of patients with and without bacterial isolates from surgical
site infections
Variable Bacteria isolated
from SSI (n = 216)
No bacteria isolated
from SSI (n = 98)
OR [95% CI] P-value
Age (years) ≤ 19 38 (67.9%) 18 (32.1%) 1
20 – 39 133 (63.6%) 76 (36.4%) 0.83(0 .42- 1.61) 0.5577
40 – 59 31 (91.2%) 3 (8.8%) 4.89( 1.24- 27.87) 0.0112
≥ 60 14 (93.3%) 1 (6.7%) 6.63( 0.86- 295.67) 0.0478
Sex Male 61 (81.3%) 14 (18.7%) 1
Female 155 (64.9%) 84 (35.1%) 0.42(0 .21- 0.82) 0.0072
Ward type Obst & Gyn 115 (59.0%) 80 (41%) 1
General Surgery 89 (85.6%) 15 (14.4%) 4.13( 2.17- 8.22) 0.0000
Orthopedic 12 (80.0%) 3 (20.0%) 2.78(0.72- 15.79) 0.1085
Operation Elective 57 (83.8%) 11 (16.2%) 1
Emergency 159 (64.6%) 87 (35.4%) 0.35( 0.16- 0.73) 0.0025
Duration from admission to operation ≤ 1 day 147 (65.3%) 78 (34.7%) 1
> 1 days 69 (77.5%) 20 (22.5%) 1.83( 1.01- 3.42) 0.0356
Duration from admission to discharge ≤ 14days 48 (58.5%) 34 (41.5%) 1
> 14days 110 (82.7%) 23 (17.3%) 3.39( 1.73- 6.68) 0.0001
Antibiotic chemoprophylaxis CRO* 124 (62.9%) 73 (37.1%) 1
CRO* +MZ** 70 (76.9%) 21 (23.1%) 1.96( 1.08- 3.65) 0.0187
Others× 22 (84.6%) 4 (15.4%) 3.24( 1.04- 13.37) 0.0289
Duration of Postoperative antibiotics ≤ 3days 48 (50.5%) 47 (49.5%) 1
> 3days 168 (76.7%) 51 (23.3%) 3.23( 1.87- 5.54) 0.0001
Outcome Improved 147 (72.1%) 57 (27.9%) 1
Died 10 (100.0%) 0 (0.0%) - 0.042
*Ceftriaxone, **Metronidazole, ×Ampicloxacillin, Ciprofloxacin & Gentamicin.
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ation from admission to discharge, longer duration of
postoperative antibiotics and outcome were statistically
associated with bacteria isolation from SSIs (see Table 3).
Of ten patients who died, 70% (7/10) had ESBL producing
Enterobacteriaceae, four of which were E. coli.Table 3 Multivariate logistic regression analysis for
factors associated with bacterial isolation from SSIs
Variable OR 95% CI p-value
Age (years) 1.16 0.74 - 1.80 0.524
Sex 1.41 0.49 - 4.02 0.522
Wards 0.44 0.18 - 1.10 0.078
Operation 0.62 0.24 - 1.65 0.343
Duration from admission to operation 0.89 0.40 - 1.97 0.773
Duration from admission to discharge 1.93 1.01 - 3.72 0.047
Antibiotic chemoprophylaxis 1.27 0.77 - 2.12 0.351
Duration of postoperative antibiotics 2.52 1.45 - 4.36 0.001
Outcome 0.52 0.30 - 0.91 0.021Discussion
Of the 314 patients with clinical SSIs enrolled in this
study; the mean age (29.7 ± 13.14 years), higher female
proportion (76.1%) and preponderance of admission in
obstetrics and gynecology wards (62.1%) was similar to
another study [11], but the proportion of female in other
studies were between 30% to 60% and wards of admis-
sion varied reflecting the underlying surgical procedures
[8,9,13]. Caesarean section and laparotomy accounted for
more than three quarters of all surgical procedures in this
study whereas other similar studies have also found these
procedures to be quite common [8,11,27]. The predomin-
ance of SSIs cases in obstetrics and gynecology wards is
quite alarming and thus, a need to institute stringent in-
fection prevention and control measures in this setting,
more especially in emergency surgeries which accounted
for more SSIs cases as opposed to elective surgeries.
As noted from other studies [8,9,11,28], S. aureus and
E. coli were the most common bacterial isolates from
SSIs. However their sources remain unknown from the
present study though other studies have documented
both endogenous and exogenous sources from hospital
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to other related studies [9,18,31], high level of resistance
was found among commonly used antibiotics like ampi-
cillin, trimethoprim-sulphamethoxazole, and tetracycline
in both Gram-positive and Gram-negative bacteria. Gram-
negative bacteria showed more resistance to gentamicin,
ciprofloxacin and chloramphenicol as compared to Gram-
positive bacteria. With exception of Acinetobacter spp, all
Gram-negative bacteria displayed low resistance rates to
piperacillin-tazobactam, amikacin and imipenem. There
were also low resistance rates of Acinetobacter spp and
P. aeruginosa to colistin. These findings are similar to
another study [17]. The present study has shown that
the rates of resistance to erythromycin (46.9%) among S.
aureus was relatively low compared to that of Entero-
coccus spp (65.2%), with excellent performance of vanco-
mycin on both S. aureus and Enterococcus spp. These
findings are in agreement to another study [18]. This study
found more MDR among Gram-negative bacteria than
Gram-positive bacteria; of these the proportion of MRSA
(37.5%) among S. aureus isolates was more than previously
reported (25.0% and 31.5%) from Uganda [9,21] and other
countries [8,16,18]. Thus, while β-lactamase-resistant anti-
biotics such as cloxacillin could still be effective in this
setting, they are likely to be ineffective against the 38%
of isolates that were confirmed as MRSA. The fact that
we found no vancomycin resistance among S. aureus iso-
lates shows that this drug remains the last resort in sys-
temic infections caused by MRSA in this setting. Previous
studies [11,17] have shown low rates (14% to 22%) of
ESBL-producers among Enterobacteriaceae isolates but the
present study and another similar study in the same region
[8] have shown ESBL-producers to account more than
three quarter of Enterobacteriaceae. This can be attributed
to the empirical use of third generation cephalosporins
(usually in combination with another drug such as genta-
micin) in almost all hospitalized patients and lack of anti-
microbial resistance surveillance in surgical wards at
Mulago National Hospital. This is a major threat to patient
care as ESBL production renders use of these ceftriaxone
or ceftazidime useless. Absence of resistance to imepenem
among these isolates is however a good finding, except that
imepenem remains an expensive drug.
Multivariate logistic regression analysis of clinical and
demographic characteristics of patients with SSIs in this
study showed that longer duration from admission to dis-
charge, longer duration of postoperative antibiotics and
outcome (death) were associated with bacteria isolation
from SSIs. These findings have also been shown in other
similar studies [5,11,27].
Limitation
The study did not isolate strict anaerobes, which could
have increased the number of bacterial isolates currentlyreported as negative cultures. This was because of lack of
standardized in-house detection methods and lack of an-
aerobic detection panels in the Phoenix Automated instru-
ment (Becton-Dickson, Sparks Maryland) that we used.
Conclusion
Most SSIs at Mulago National Hospital are due to MDR
bacteria, these are significantly more among Gram-negative
than Gram-positive bacteria. Isolation of MRSA and ESBL-
producing Enterobacteriaceae in higher proportions than
previously reported calls for enhanced antibiotic steward-
ship including laboratory guided SSIs-therapy and strength-
ening of infection control surveillance by identifying
sources of these MDR isolates. In the light of these findings,
there is a need to investigate whether there is clonal spread
of the predominant bacteria within/or among surgical
wards at Mulago National Hospital.
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